Clinician characteristics associated with use of risk assessment models for venous thromboembolism and bleeding in hospitalized patients.
作者信息
Bulteel Alexander J B, Barnum Kevin, Datta Siddhant, Dodge Laura E, Lake Leslie, Elavalakanar Pavania, Lam Barbara D, Patell Rushad
机构信息
Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA.
Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
出版信息
Ann Hematol. 2025 Jun;104(6):3531-3536. doi: 10.1007/s00277-025-06380-4. Epub 2025 May 7.
Abstract
摘要
相似文献
1
Clinician characteristics associated with use of risk assessment models for venous thromboembolism and bleeding in hospitalized patients.与住院患者静脉血栓栓塞和出血风险评估模型使用相关的临床医生特征。
Ann Hematol. 2025 Jun;104(6):3531-3536. doi: 10.1007/s00277-025-06380-4. Epub 2025 May 7.
2
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
3
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
4
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
5
Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.妊娠期和产褥期的血栓预防：一项系统评价和经济评估，以估算未来研究的价值。
Health Technol Assess. 2024 Mar;28(9):1-176. doi: 10.3310/DFWT3873.
6
Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.他汀类药物与静脉血栓栓塞症的一级预防：一项系统评价和荟萃分析。
Lancet Haematol. 2017 Feb;4(2):e83-e93. doi: 10.1016/S2352-3026(16)30184-3. Epub 2017 Jan 13.
7
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
8
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.首次特发性静脉血栓栓塞症治疗后静脉血栓栓塞症复发风险的预测：系统评价、预后模型与临床决策规则以及经济学评估
Health Technol Assess. 2016 Feb;20(12):i-xxxiii, 1-190. doi: 10.3310/hta20120.
9
Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.采用混合治疗比较的荟萃分析方法评估口服抗凝剂用于静脉血栓栓塞症的长期治疗。
Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.
10
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.对无抗凝治疗或预防指征的癌症患者进行肠外抗凝。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD006652. doi: 10.1002/14651858.CD006652.pub2.
本文引用的文献
1
Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices.住院成年患者的静脉血栓栓塞预防：美国医疗保健提供者对态度和实践的调查。
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102168. doi: 10.1016/j.rpth.2023.102168. eCollection 2023 Aug.
2
Thromboembolism Prophylaxis for Patients Discharged From the Hospital: Easier Said Than Done.出院患者的血栓栓塞预防：说起来容易做起来难。
J Am Coll Cardiol. 2020 Jun 30;75(25):3148-3150. doi: 10.1016/j.jacc.2020.05.023.
3
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.美国血液学会 2018 年静脉血栓栓塞症管理指南：住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
4
Venous Thromboembolism Prophylaxis: Inadequate and Overprophylaxis When Comparing Perceived Versus Calculated Risk.静脉血栓栓塞预防：比较感知风险与计算风险时的预防不足和过度预防
Mayo Clin Proc Innov Qual Outcomes. 2017 Dec 1;1(3):242-247. doi: 10.1016/j.mayocpiqo.2017.10.003. eCollection 2017 Dec.
5
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
6
Incidence of in-hospital and post-discharge diagnosed hospital-associated venous thromboembolism using linked administrative data.利用关联管理数据得出的住院期间及出院后诊断的医院相关性静脉血栓栓塞症的发病率。
Intern Med J. 2018 Feb;48(2):157-165. doi: 10.1111/imj.13679.
7
The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.美国住院患者静脉血栓栓塞症的发病率及经济负担
J Arthroplasty. 2017 Apr;32(4):1063-1066. doi: 10.1016/j.arth.2016.10.020. Epub 2016 Oct 21.
8
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中，HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
9
A review of venous thromboembolism prophylaxis for hospitalized medical patients.住院内科患者静脉血栓栓塞症预防措施的综述
Hosp Pract (1995). 2013 Aug;41(3):60-9. doi: 10.3810/hp.2013.08.1069.
10
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.利伐沙班用于急性病医学患者的血栓预防。
N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.
Zotero 插件